IL20RB and acute lymphoblastic leukemia: We confirmed this statistically significant correlation between BMAL1/IL20RB and CLOCK/IL20R expression levels in three large T-ALL patients cohorts, totaling 519 patients’ samples [49–52] (Fig. 6B), supporting the relevance of this functional axis in T-ALL patients as well.